Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun A CETP inhibitor.

Etymologies

Sorry, no etymologies found.

Examples

  • Swiss pharmaceutical company Roche also has a CETP drug, called dalcetrapib, in late-stage clinical trials in partnership with Japan Tobacco, in which it sees great potential.

    Latest News - Yahoo!7 News

  • Swiss pharmaceutical company Roche also has a CETP drug, called dalcetrapib, in late-stage clinical trials in partnership with Japan Tobacco, in which it sees great potential.

    Latest News - Yahoo!7 News

  • Swiss pharmaceutical company Roche also has a CETP drug, called dalcetrapib, in late-stage clinical trials in partnership with Japan Tobacco, in which it sees great potential.

    FinanzNachrichten.de: Aktuelle Nachrichten

  • Swiss pharmaceutical company Roche also has a CETP drug, called dalcetrapib, in late-stage clinical trials in partnership with Japan Tobacco, in which it sees great potential.

    Stuff.co.nz - Stuff

  • Swiss pharmaceutical company Roche also has a CETP drug, called dalcetrapib, in late-stage clinical trials in partnership with Japan Tobacco, in which it sees great potential.

    Latest News - Yahoo!7 News

  • Roche plans in 2013 to seek regulatory approval of another medicine, called dalcetrapib, which works by boosting levels of good cholesterol.

    BusinessWeek.com --

  • Swiss pharmaceutical company Roche also has a CETP drug, called dalcetrapib, in late-stage clinical trials in partnership with Japan Tobacco, in which it sees great potential.

    FinanzNachrichten.de: Aktuelle Nachrichten

  • Swiss pharmaceutical company Roche also has a CETP drug, called dalcetrapib, in late-stage clinical trials in partnership with Japan Tobacco, in which it sees great potential.

    Latest News - Yahoo!7 News

  • LONDON—Shares in Roche AG were boosted Monday after the Swiss drug maker reported encouraging results from clinical trials of dalcetrapib, a drug designed to raise "good" cholesterol.

    Roche Boosted By Drug-Trial Data

  • "If, however, one or more of the CETP inhibitors make it to market, they could be multi-billion dollar drugs," they said, adding that dalcetrapib could make a real difference even for a company as large as Roche.

    Roche Boosted By Drug-Trial Data

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.